LIS
REGN icon

Legacy Investment Solutions’s Regeneron Pharmaceuticals REGN Stock Holding History

Legacy Investment Solutions’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$1.05K Buy
+2
New +$1.12K ﹤0.01% 590
2024
Q4 		$12.8K Buy
18
+16
+800% +$13.4K 0.01% 253
2024
Q3 		$1.61K Buy
+2
New +$2.23K ﹤0.01% 499

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legacy Investment Solutions's REGN Position: Q2 2025 in Review

Legacy Investment Solutions opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2025: 2 shares worth $1.05K. The stake represents ﹤0.01% of the portfolio and ranks #590 among its holdings. This is a return to the name: Legacy Investment Solutions previously reported a position in REGN as recently as Q4 2024.

Legacy Investment Solutions first reported a position in REGN in Q3 2024 and has held it in 3 quarters since. The position peaked at $12.8K in Q4 2024. 1,202 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

  • Legacy Investment Solutions held 2 shares of Regeneron Pharmaceuticals worth $1.05K as of Q2 2025.
  • Regeneron Pharmaceuticals was a new Legacy Investment Solutions position in Q2 2025.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Legacy Investment Solutions's portfolio in Q2 2025, its #590 holding.
  • Legacy Investment Solutions first reported a position in Regeneron Pharmaceuticals in Q3 2024 and has held it in 3 quarters since.
  • Legacy Investment Solutions's Regeneron Pharmaceuticals position peaked at $12.8K in Q4 2024.
  • 1,202 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on Legacy Investment Solutions's 13F filing for Q2 2025, filed 6 Aug 2025.